The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,771.00
Bid: 1,770.50
Ask: 1,771.00
Change: 10.00 (0.57%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,772.50
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 up as AstraZeneca, GSK climb on vaccine hopes

Thu, 28th May 2020 09:30

* Cineworld among top FTMC performers on plans for July
reopening

* AstraZeneca up 4.4% after outlining COVID-19 treatment
trials

* GSK up 2% on plans for vaccine booster production
(Adds details, updates to close)

By Sagarika Jaisinghani and Ambar Warrick

May 28 (Reuters) - UK shares ended higher on Thursday,
helped by drugmakers AstraZeneca and GSK as markets looked for
more progress in the development of a COVID-19 vaccine, while
optimism over the reopening of the economy persisted.

The blue-chip FTSE 100 rose another 1.2% after
ending Wednesday at an 11-week high, with AstraZeneca
the biggest boost.

The group, which is developing a leading coronavirus vaccine
with Oxford University, said it may have to consider introducing
vaccine trial participants to the virus.

GSK was the second biggest boost to the index as it
laid out plans to produce 1 billion doses of vaccine efficacy
boosters for COVID-19 shots next year.

While markets are looking forward to the ending of
virus-driven lockdowns, a vaccine would cement a return to
economic normalcy by negating the need for disruptive social
distancing.

The mid-cap FTSE 250 closed 1.1% higher, gaining for
the ninth session in a row as British employers turned slightly
less pessimistic about hiring.

Cinema operator Cineworld was among the best
performers on the mid-cap index as it planned to reopen all its
cinemas in July. It also secured an additional $110 million from
lenders and a waiver on loan covenants.

"Investors are not positioning their trades based on the
expected next two or three quarters' earnings," said FXTM market
strategist Hussein Sayed. "They are looking well beyond that."

"What seems to be priced in is the economy will recover much
faster than previously estimated, the pandemic will soon end and
life will return to normal."

Rebounding from a sharp coronavirus-led selloff in March, UK
stocks are on course for their biggest two-month gain since the
global financial crisis despite brewing U.S.-China tensions and
forecasts of a deep global recession.

Bank of England Governor Andrew Bailey said on Wednesday the
economy was at risk of a longer-than-expected recovery, but
hopes of even more stimulus have kept financial markets
optimistic.
(Reporting by Sagarika Jaisinghani in Bengaluru; Editing by
Shounak Dasgupta and Jan Harvey)

More News
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.